Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2016, Article ID 6104948, 3 pages
http://dx.doi.org/10.1155/2016/6104948
Case Report

Pregnancy and Accelerated Phase of Myeloid Chronic Leukemia Treated with Imatinib: A Case Report from a Developing Country

Department of Medical Hematology, Brazzaville Teaching Hospital, 13 Avenue Auxence Ikonga, BP 32, Brazzaville, Congo

Received 11 January 2016; Accepted 17 March 2016

Academic Editor: Massimo Gentile

Copyright © 2016 Lydie Ocini Ngolet et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. G. Koffi, D. C. Nanho, E. N'Dathz et al., “The effect of imatinib mesylate for newly diagnosed philadelphia chromosome-positive, chronic-phase myeloid leukemia in sub-saharan african patients: the experience of Côte d'Ivoire,” Advances in Hematology, vol. 2010, Article ID 268921, 6 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. A. D. Muheez, O. F. Julius, A. Oyekunle et al., “The use of Imatinib mesylate in Nigerians with chronic myeloid leukemia,” Cellular Therapy and Transplantation, vol. 1, no. 2, p. 15, 2008. View at Google Scholar
  3. M. Celiloglu, S. Altunyurt, and B. Undar, “Hydroxyurea treatment for chronic myeloid leukemia during pregnancy,” Acta Obstetricia et Gynecologica Scandinavica, vol. 79, no. 9, pp. 803–804, 2000. View at Publisher · View at Google Scholar
  4. A. Bhandar, K. Rolen, and B. Shah Kumar, “Management of chronic myelogenous leukemia in pregnancy,” Anticancer Research, vol. 35, pp. 1–11, 2015. View at Google Scholar
  5. R. Palani, D. Milojkovic, and J. F. Apperley, “Managing pregnancy in chronic myeloid leukemia,” Annals of Hematology, vol. 94, supplement 2, pp. S167–S176, 2015. View at Google Scholar
  6. S. M. Pye, J. Cortes, P. Ault et al., “The effects of imatinib on pregnancy outcome,” Blood, vol. 111, no. 12, pp. 5505–5508, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. H. Lipton, C. M. Derzko, and J. Curtis, “Alpha-interferon and pregnancy in a patient with CML,” Hematological Oncology, vol. 14, no. 3, pp. 119–122, 1996. View at Google Scholar · View at Scopus
  8. R. Ali, F. Özkalemkaş, V. Özkocaman et al., “Successful pregnancy and delivery in a patient with chronic myelogenous leukemia (CML), and management of CML with leukapheresis during pregnancy: a case report and review of the literature,” Japanese Journal of Clinical Oncology, vol. 34, no. 4, pp. 215–217, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Ali, F. Ozkalemkas, T. Ozcelik, V. Ozkocaman, and A. Ozkan, “Imatinib and pregnancy,” Journal of Clinical Oncology, vol. 24, no. 23, pp. 3812–3813, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Iqbal, Z. Ali, A.-U. Khan, and Z. Aziz, “Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country,” Leukemia and Lymphoma, vol. 55, no. 9, pp. 2109–2113, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. A. W. Fadilah, H. Ahmad-Zailani, C. Soon-Keng, and M. Norlaila, “Successful treatment of chronic myeloid leukemia during pregnancy with hyroxyurea,” Leukemia, vol. 16, no. 6, pp. 1202–1203, 2002. View at Publisher · View at Google Scholar · View at Scopus